Institution · Deutsche Knochenmarkspenderdatei

Most cited papers from Deutsche Knochenmarkspenderdatei

Deutsche Knochenmarkspenderdatei

What are the most cited papers from Deutsche Knochenmarkspenderdatei?

The most cited paper from Deutsche Knochenmarkspenderdatei is "A vaccine targeting mutant IDH1 in newly diagnosed glioma" (Michael Platten et al., 2021), with 442 citations. Next come "Integrative genomic and transcriptomic analysis of leiomyosarcoma" (314) and "Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing" (283).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 32 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A vaccine targeting mutant IDH1 in newly diagnosed glioma Michael Platten et al. · Nature Open access	24 Mar 2021	442
2	Integrative genomic and transcriptomic analysis of leiomyosarcoma Priya Chudasama et al. · Nature Communications Open access	4 Jan 2018	314
3	Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing Vinzenz Lange, Irina Böhme, Jan A. Hofmann et al. · BMC Genomics Open access	24 Jan 2014	283
4	Condensation of Ded1p Promotes a Translational Switch from Housekeeping to Stress Protein Production Christiane Iserman, Christine Desroches Altamirano, Ceciel Jegers et al. · Cell Open access	30 Apr 2020	260
5	DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy Katrin Töpfer, Marc Cartellieri, Susanne Michen et al. · The Journal of Immunology	4 Mar 2015	252
6	Immunomodulatory Properties of Mesenchymal Stromal Cells and Their Therapeutic Consequences for Immune-Mediated Disorders Senming Zhao, Rebekka Wehner, Martin Bornhäuser et al. · Stem Cells and Development	13 Oct 2009	229
7	Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy Marc Schmitz, Achim Temme, Volker Senner et al. · British Journal of Cancer Open access	20 Mar 2007	207
8	Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0 Carolyn Katovich Hurley et al. · HLA Open access	22 Jan 2020	181
9	Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies Leo Luznik et al. · Journal of Clinical Oncology Open access	2 Dec 2021	179
10	CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome Franziska Taube et al. · Blood Open access	28 Jul 2021	174
11	Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? Christoph Röllig et al. · Blood Open access	4 Jun 2020	137
12	Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning Alexander H. Schmidt, Daniel M Baier, Ute V. Solloch et al. · Human Immunology	14 Aug 2009	135
13	Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults Florian Ganzer, Sonja Bröning, Stefanie Kraft et al. · Neuropsychology Review Review	28 Apr 2016	127
14	Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers Ute V. Solloch, Kathrin Lang, Vinzenz Lange et al. · Human Immunology Open access	11 Oct 2017	112
15	2.7 million samples genotyped for HLA by next generation sequencing: lessons learned Gerhard Schöfl, Kathrin Lang, Philipp Quenzel et al. · BMC Genomics Open access	14 Feb 2017	109
16	Ancient DNA study reveals HLA susceptibility locus for leprosy in medieval Europeans Ben Krause‐Kyora et al. · Nature Communications Open access	16 Apr 2018	102
17	Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors S. Parmentier, Johannes Schetelig, Kerstin Lorenz et al. · Haematologica Open access	16 Dec 2011	91
18	Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers Arne Eric Jahn et al. · Annals of Oncology Open access	18 Aug 2022	86
19	Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations Ines Wagner, Daniel Schefzyk, Jens Pruschke et al. · Frontiers in Immunology Open access	4 Dec 2018	79
20	High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: How can they be used to improve unrelated donor searches? Julia Pingel, Ute V. Solloch, Jan A. Hofmann et al. · Human Immunology	29 Nov 2012	76
21	Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation Michel van Gelder et al. · Bone Marrow Transplantation Open access	12 Dec 2016	74
22	Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation Jan Moritz Middeke, Min Fang, Jan J. Cornelissen et al. · Blood	21 Mar 2014	74
23	Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Jan‐Niklas Eckardt et al. · Journal of Hematology & Oncology Open access	13 May 2022	68
24	Dual redundant sequencing strategy: Full‐length gene characterisation of 1056 novel and confirmatory HLA alleles Viviane Albrecht, Carolin Zweiniger, Vineeth Surendranath et al. · HLA Open access	25 May 2017	67
25	ABO allele-level frequency estimation based on population-scale genotyping by next generation sequencing Kathrin Lang, Ines Wagner, Bianca Schöne et al. · BMC Genomics Open access	20 May 2016	67
26	Bioinformatics Strategies, Challenges, and Opportunities for Next Generation Sequencing-Based HLA Genotyping Steffen Klasberg, Vineeth Surendranath, Vinzenz Lange et al. · Transfusion Medicine and Hemotherapy Open access	2019	65
27	Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial Martin Wermke, Julia Eckoldt, Katharina S. S. Götze et al. · The Lancet Haematology	6 Apr 2018	60
28	Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation Kavita K Raj et al. · Transplantation and Cellular Therapy Open access	5 Nov 2018	58
29	Genetic basis of allochronic differentiation in the fall armyworm Sabine Hänniger, Pascaline Dumas, Gerhard Schöfl et al. · BMC Evolutionary Biology Open access	6 Mar 2017	58
30	Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation Friedrich Stölzel, Karl Hackmann, Friederike Kuithan et al. · Transplantation	7 Feb 2012	58
31	High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20,653 stem cell donors Alexander H. Schmidt, Ute V. Solloch, Julia Pingel et al. · Human Immunology	21 Apr 2011	58
32	Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia Uwe Platzbecker, Christian Thiede, Monika Füssel et al. · Leukemia	16 Feb 2006	57
33	EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia Sebastian Stasik et al. · Haematologica Open access	14 Aug 2019	56
34	External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails Johannes Schetelig et al. · Blood Open access	14 Jan 2020	55
35	Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Francesco Onida et al. · British Journal of Haematology Open access	28 Mar 2017	54
36	Hapl-o-Mat: open-source software for HLA haplotype frequency estimation from ambiguous and heterogeneous data Christian Schäfer, Alexander H. Schmidt, Jürgen Sauter · BMC Bioinformatics Open access	30 May 2017	53
37	Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial Matthias Stelljes et al. · The Lancet Haematology Open access	4 Apr 2024	52
38	Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples Bianca Schöne, Sabine Bergmann, Kathrin Lang et al. · Human Immunology Open access	7 Nov 2017	52
39	Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors Raphael Teipel, Johannes Schetelig, Michael Krämer et al. · Transfusion	16 Jul 2015	50
40	Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Jan Moritz Middeke et al. · Blood Advances Open access	18 Nov 2021	49
41	Analysis of Genomic DNA from Medieval Plague Victims Suggests Long-Term Effect of Yersinia pestis on Human Immunity Genes Alexander Immel et al. · Molecular Biology and Evolution Open access	13 May 2021	48
42	Clonal hematopoiesis and its emerging effects on cellular therapies Malte v. Bonin, Helena Klara Jambor, Raphael Teipel et al. · Leukemia Open access	2 Jul 2021	46
43	Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile Caroline Pfeifer, Andrew J. Highton, Sven Peine et al. · Frontiers in Immunology Open access	19 Dec 2018	46
44	Body odours as a chemosignal in the mother–child relationship: new insights based on an human leucocyte antigen-genotyped family cohort Laura Schäfer, Agnieszka Sorokowska, Jürgen Sauter et al. · Philosophical Transactions of the Royal Society B Biological Sciences Open access	19 Apr 2020	45
45	Dynamics of epigenetic age following hematopoietic stem cell transplantation Friedrich Stölzel, Mario Brosch, Steve Horvath et al. · Haematologica Open access	26 May 2017	45
46	High-Throughput MICA/B Genotyping of Over Two Million Samples: Workflow and Allele Frequencies Anja Klußmeier, Carolin Massalski, Kathrin Putke et al. · Frontiers in Immunology Open access	21 Feb 2020	44
47	Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation Johannes Schetelig et al. · Bone Marrow Transplantation Open access	23 Jan 2017	44
48	In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial Matthias Stelljes et al. · Blood	15 Nov 2022	42
49	Immunogenetics in stem cell donor registry work: The DKMS example (Part 1) Alexander H. Schmidt et al. · International Journal of Immunogenetics Open access	6 Jan 2020	39
50	Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation James S. O’Donnell, JM Goldman, Karl Gerhard Wagner et al. · Bone Marrow Transplantation	Feb 1998	39

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.